Skip to main content
. 2021 Sep 15;94(1):291–297. doi: 10.1002/jmv.27319

Table 1.

Baseline characteristics of COVID‐19 patients with severe/critical illness in the first versus second wave

Variable First wave (n = 228) Second wave (n = 681) p Value
Age (years) 64.5 (54–74.7) 65(54–73) 0.65
Male, n (%) 129 (56.6) 391 (57.4) 0.87
Comorbidities, n (%)
Any comorbidity 155 (68) 486 (71.4) 0.35
Hypertension 99 (43.4) 317 (46.5) 0.44
Diabetes mellitus 71 (31.1) 233 (34.2) 0.41
Asthma 18 (7.9) 55 (8.1) NS
COPD 17 (7.5) 49 (7.2) 0.22
Ischemic heart disease 27 (11.9) 96 (14.1) 0.43
Hyperlipidemia 10 (4.4) 42 (6.2) 0.41
Chronic renal disease 12 (5.3) 48(7) 0.03
Malignity 5 (2.2) 19 (2.8) 0.81
Congestive heart failure 15 (6.6) 52 (7.6) 0.66
Rheumatologic disease 3 (1.3) 21 (3.1) 0.23
Neurologic disease 15 (6.6) 42 (6.2) 0.87
C‐reactive protein (mg/L)a 87 (39–140) 109 (65–157) <0.001
Length of hospitalization (days) 11 (7.2–17) 10 (7–15) 0.04
Time from hospitalization to ICU admission (days) 5 (3–7.7) 3 (0‐6) 0.01
Admission to ICU, n (%) 64 (28.1) 191 (28) NS
IMV in ICU, n (%) 48 (21.1) 137 (20.1) 0.76
Mortality, n (%) 46 (20.2) 149 (21.9) 0.64

Note: Those with significant p values are indicated in bold (p values < 0.05 indicated that the difference was statistically significant). All continuous variables were reported as median and interquartile range.

Abbreviations: COPD, chronic obstructive pulmonary disease; ICU, intensive care unit; IMV, invasive mechanical ventilation; NS, not significant (p = 1.00); SD, standard deviation.

a

CRP normal range is between 0 and 5 mg/L.